Potential candidate variables include specific genetic markers (e.g., homozygous prothrombin G20210A), PFO morphology (e.g., large shunt or atrial septal aneurysm), coagulation profiles, and clinical indicators like a history of venous thromboembolism or elevated RoPE scores. The gene discussed is F2; the disease is Patent foramen ovale.